Nov 29, 2018

Philips completes cancellation of 24.2 million shares

Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has completed the cancellation of 24,246,711 of its shares, as part of Philips’ EUR 1.5 billion share repurchase program, which started in the third quarter of 2017. The cancelled shares were acquired during the period up to and including November 23, 2018.

Under this share repurchase program, which is being executed over a two-year period, Philips has also entered into a number of forward transactions with a number of financial institutions, to be settled at future dates over the course of the program. The program is expected to result in the acquisition and cancellation of an additional 22.7 million shares. Further details can be found here.

Philips’ current issued share capital amounts to 926,195,539 shares.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read more Click here to read less